A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder

Clinical trial NCT00368030 · COMPLETED

Trial details

NCT number: NCT00368030
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Insomnia Depressive Disorder, Major

Start date: 2004-01-01
Primary completion: 2004-10-01
Enrollment: 545

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.